Wacker Chemie Temettüler ve Geri Alımlar
Temettü kriter kontrolleri 0/6
Wacker Chemie şu anda temettü ödemiyor.
Anahtar bilgiler
0%
Temettü verimi
n/a
Geri Alım Getirisi
| Toplam Hissedar Getirisi | n/a |
| Gelecekteki Temettü Verimi | 2.2% |
| Temettü Büyümesi | n/a |
| Bir sonraki temettü ödeme tarihi | n/a |
| Eski temettü tarihi | n/a |
| Hisse başına temettü | n/a |
| Ödeme oranı | 0% |
Son temettü ve geri alım güncellemeleri
Recent updates
Anlatı Güncellemesi • Sep 03
WCH: Semi Cycle Caution And Margin Outlook Will Shape Fair Value
Analysts have trimmed their fair value estimate for Wacker Chemie to €104 from €110, reflecting a lower Street price target, now at €85, that is linked to concerns that recent share gains may already factor in much of the expected benefit from the semiconductor cycle. Analyst Commentary Recent Street research on Wacker Chemie has leaned cautious, with price targets centred around €85 and commentary that recent share gains may already reflect a large part of the expected benefit from the semiconductor cycle.
Anlatı Güncellemesi • Aug 17
WCH: Semi Cycle Euphoria And 40% Rally Will Likely Cap Returns
Analysts have nudged their fair value estimate for Wacker Chemie higher to about €70 from about €67, citing higher Street price targets around €95 to €104 and arguing that recent share gains may already reflect much of the expected benefit from the semiconductor cycle. Analyst Commentary Recent Street commentary on Wacker Chemie highlights a more cautious tone after the stock's strong move, with several bearish analysts questioning how much upside is left at current levels.Anlatı Güncellemesi • Aug 03
WCH: Higher Margin Outlook Will Support Fair Value Beyond Post Rally Downgrades
Analysts now see a fair value for Wacker Chemie at €110 per share, with updated assumptions that include a slightly lower discount rate, a modest adjustment to revenue growth, a higher profit margin outlook, and a marginally lower future P/E. These revisions are informed by recent price target changes and more cautious views on how much the company may benefit from the semiconductor cycle after its strong share price rally.Anlatı Güncellemesi • Jul 20
WCH: Semi Cycle Optimism And Rally Will Likely Cap Future Returns
Analysts have raised the fair value estimate for Wacker Chemie from about €61.46 to roughly €66.76. This reflects updated views on margins and revenue potential, even as recent Street research has shifted to more cautious ratings following the stock's strong rally.Anlatı Güncellemesi • Jul 01
WCH: Elevated P/E And Semi Cycle Optimism Will Likely Undermine Future Returns
Wacker Chemie’s updated fair value estimate has moved from about €50 to roughly €61, as analysts lift price targets after the stock’s rally while highlighting more cautious assumptions on margins and the semi cycle. Analyst Commentary Recent research on Wacker Chemie points to a more balanced, and in parts cautious, stance after the share price rally, with several bearish analysts flagging valuation, execution, and growth risks even as some major banks lift price targets.
Anlatı Güncellemesi • Jun 17
WCH: Future Returns Will Rely On Delivering Cautious 2026 Semiconductor Cycle Assumptions
The analyst price target for Wacker Chemie has moved higher from about €81 to about €89. Analysts point to revised assumptions on revenue growth, profit margins and future P/E multiples, even as some recent downgrades highlight concerns that the stock's rally may already reflect much of the expected benefit from the semiconductor cycle.Anlatı Güncellemesi • Jun 02
WCH: Higher P/E Assumptions Will Balance Rally With Measured Medium Term Upside
Analysts have raised their fair value estimate for Wacker Chemie from €96 to €110, citing a series of recent price target increases across the Street and updated assumptions for revenue growth, profit margins, and future P/E. Some now see more limited upside following the stock's strong run.Anlatı Güncellemesi • May 02
WCH: Future Returns Will Depend On Delivering Cautious 2026 Earnings Guidance
Analysts have lifted their fair value estimate for Wacker Chemie from €73.50 to about €81.43, citing updated assumptions on revenue growth, profitability and future P/E multiples following several recent upgrades and price target increases from major research houses. Analyst Commentary Bullish Takeaways Bullish analysts point to a series of recent upgrades as support for a higher fair value range, linking their stance to refreshed assumptions on revenue, margins and the P/E multiple they are willing to apply.Anlatı Güncellemesi • Apr 17
WCH: Supportive Research Tone Will Sustain Richer Future P/E Expectations
Analysts have nudged the fair value estimate for Wacker Chemie up to €96.00 from about €95.45, citing a higher assumed revenue growth rate, a revised future P/E of roughly 20.7, and a series of recent price target increases and upgrades from major banks. Analyst Commentary Recent Street research has tilted more supportive, with several bullish analysts revising their views in a way that reinforces the higher fair value estimate and the assumed future P/E of about 20.7. Some have raised price targets, including one increase to €61 from €59 alongside an Underweight rating, while others have moved to more positive stances through upgrades and more constructive commentary.Anlatı Güncellemesi • Apr 02
WCH: Future Returns Will Depend On Delivering Modest 2026 Guidance
Analysts have lifted the implied fair value estimate for Wacker Chemie from about €69.57 to €73.50. This reflects recent upgrades and a higher Street price target of €61, which collectively point to adjusted assumptions on revenue growth, margins and future P/E multiples.Anlatı Güncellemesi • Mar 18
WCH: Higher P/E Assumptions Will Likely Fail To Support Rich Share Price
Analysts have lifted their price target on Wacker Chemie to €61 from €59, reflecting updated views on revenue growth, profit margins and future P/E assumptions, while keeping the fair value estimate unchanged. Analyst Commentary Recent research on Wacker Chemie points to a mixed backdrop, with some price target adjustments reflecting caution around execution risks, earnings visibility and how the shares are valued against these factors.Anlatı Güncellemesi • Mar 04
WCH: Margin Execution Risks Will Likely Cap Share Upside Despite Upgrades
Analysts have raised their price target on Wacker Chemie to €50, citing firmer margin expectations and a lower assumed future P/E, supported by recent upgrades from major houses. Analyst Commentary Recent research reports on Wacker Chemie point to a more constructive view on margins and valuation, but you still see a strand of caution in the background.Anlatı Güncellemesi • Feb 18
WCH: Improved Earnings Profile Will Support Richer Future P/E Multiple
Analysts have trimmed their price target on Wacker Chemie to about €95 from roughly €108, citing revised expectations for revenue growth, profitability and a higher assumed future P/E multiple as key drivers of the change. Analyst Commentary Recent research has leaned more positive on Wacker Chemie, with bullish analysts pointing to a more constructive view on the company’s earnings power and how that could be reflected in the share price over time.Anlatı Güncellemesi • Feb 03
WCH: Fair Outlook Will Depend On Restructuring Progress And Section 232 Resolution
Analysts have nudged their fair value estimate for Wacker Chemie higher to €69.57 from €67.36, reflecting updated views on margins and P/E assumptions, alongside mixed rating actions from recent Street research. Analyst Commentary Recent Street research shows a split view on Wacker Chemie, with some analysts turning more positive while others take a more cautious stance around execution and policy risks.Anlatı Güncellemesi • Jan 20
WCH: Section 232 Uncertainty Will Likely Cap Near Term Share Upside
Analysts have adjusted their average price target for Wacker Chemie to €73, reflecting a more cautious stance that aligns with recent Neutral and Equal Weight views as they wait for clarity on Section 232 outcomes and the company’s restructuring plans. Analyst Commentary Recent commentary around Wacker Chemie has taken a more cautious tone, with coverage starting at a neutral stance and an existing recommendation cut back to Neutral alongside a €73 price target.Anlatı Güncellemesi • Jan 06
WCH: Fair Outlook Hinges On Restructuring Execution And Section 232 Outcome
Analysts have kept their fair value estimate for Wacker Chemie broadly unchanged at €67.36, with only modest tweaks to discount rate, growth and margin assumptions. They have also tempered their stance in light of mixed recent coverage and a Neutral rating with a €73 price target.Analiz Makalesi • Jan 05
Revenues Tell The Story For Wacker Chemie AG (ETR:WCH)
With a median price-to-sales (or "P/S") ratio of close to 0.6x in the Chemicals industry in Germany, you could be...Anlatı Güncellemesi • Dec 18
WCH: Restructuring Uncertainty And Trade Policy Risks Will Likely Pressure Shares
Analysts have modestly reduced their price targets for Wacker Chemie, trimming expectations by a few euros per share as they factor in slower revenue growth, thinner profit margins, and valuation headwinds while awaiting clarity on U.S. trade policy and the company restructuring. Analyst Commentary Bearish analysts have shifted to a more cautious stance on Wacker Chemie, emphasizing execution risks around the ongoing restructuring, uncertainty over U.S. trade policy decisions, and a less supportive earnings backdrop.Anlatı Güncellemesi • Dec 04
WCH: Future Performance Will Depend On Restructuring Progress And Section 232 Decisions
Analysts have trimmed their fair value estimate for Wacker Chemie by roughly EUR 1 to about EUR 67. This reflects slightly softer growth expectations and more cautious price targets following a wave of Neutral and Hold ratings.Anlatı Güncellemesi • Nov 20
WCH: Near-Term Performance Will Depend On Restructuring Progress And Policy Outcomes
Wacker Chemie's analyst price target has seen a modest decrease to €68.29 from €69, as analysts cite cautious outlooks regarding restructuring progress and ongoing external uncertainties. Analyst Commentary Recent analyst activity on Wacker Chemie has provided a spectrum of perspectives on the company’s outlook, as reflected in their updated ratings and price targets.Anlatı Güncellemesi • Nov 05
WCH: Future Earnings Will Face Margin Pressure As Cautious Outlook Persists
Wacker Chemie’s fair value estimate has been raised from €66.33 to €69.00. This change reflects analysts’ updated outlook based on adjusted forecasts for discount rates, future revenue growth, and profit margins.Analiz Makalesi • Oct 26
What Is Wacker Chemie AG's (ETR:WCH) Share Price Doing?
Wacker Chemie AG ( ETR:WCH ), might not be a large cap stock, but it saw a decent share price growth of 13% on the XTRA...Anlatı Güncellemesi • Oct 22
Analysts Mixed on Wacker Chemie as Price Targets Fall Amid Slightly Lower Growth Forecasts
Wacker Chemie's analyst price target has been revised downward from €68.92 to €66.33, with analysts citing slightly reduced expectations for revenue growth and profit margins as reasons for the change. Analyst Commentary Recent price target revisions for Wacker Chemie signal mixed sentiment in the market, as analysts evaluate the company’s prospects in light of changing expectations for revenue and profitability.Anlatı Güncellemesi • Oct 08
Polysilicon And Renewable Energy Investments Will Drive Future Value
Wacker Chemie's analyst price target has been revised downward, decreasing by approximately EUR 2.72 to EUR 68.92. Analysts note expectations for softer revenue growth and profit margins in their latest forecasts.Analiz Makalesi • Sep 29
Does Wacker Chemie (ETR:WCH) Have A Healthy Balance Sheet?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Anlatı Güncellemesi • Sep 19
Polysilicon And Renewable Energy Investments Will Drive Future Value
Analysts have lowered Wacker Chemie’s price target to €71.64, citing ongoing margin pressures, weak end-market demand, and reduced earnings visibility, driving a more cautious sector outlook. Analyst Commentary Bearish analysts cite continued margin pressures in key business segments, weighing on profit forecasts.Anlatı Güncellemesi • Sep 04
Polysilicon And Renewable Energy Investments Will Drive Future Value
Analysts have become more cautious on Wacker Chemie due to rising short-term earnings risks and macroeconomic uncertainty, resulting in price target downgrades and more conservative recommendations, with the consensus analyst price target unchanged at €75.79. Analyst Commentary Bearish analysts cite increased short-term risks to Wacker Chemie’s earnings momentum as a key factor behind lowered price targets.
Yeni Anlatı • Dec 22
Specialty Silicones And Biosolutions Expansion Will Propel Earnings And Boost Net Margins
Investment in specialty silicones and focus on high-margin specialties forecast improved net margins and earnings through enhanced portfolio management.Ödemelerde İstikrar ve Büyüme
Temettü verilerini getirme
İstikrarlı Temettü: WCH şirketinin hisse başına düşen temettülerinin geçmişte istikrarlı olup olmadığını belirlemek için yeterli veri yok.
Büyüyen Temettü: WCH şirketinin temettü ödemelerinin artıp artmadığını belirlemek için yeterli veri yok.
Piyasaya Karşı Temettü Getirisi
| Wacker Chemie Piyasaya Karşı Temettü Getirisi |
|---|
| Segment | Temettü Verimi |
|---|---|
| Şirket (WCH) | 0% |
| Pazarın Alt %25'i (DE) | 1.4% |
| Pazarın En İyi %25'i (DE) | 4.8% |
| Sektör Ortalaması (Chemicals) | 3.6% |
| Analist tahmini (WCH) (3 yıla kadar) | 2.2% |
Önemli Temettü: WCH şirketinin temettü getirisi, şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, temettü ödeyenlerin en alttaki %25'lik dilimine göre değerlendirilemiyor.
Yüksek Temettü: Şirketin yakın zamanda herhangi bir ödeme bildirmemesi nedeniyle, WCH şirketinin temettü getirisi, temettü ödeyenlerin en üst %25'ine göre değerlendirilemiyor.
Hissedarlara Ödenen Kazanç
Kazanç Kapsamı: WCH German piyasası için dikkate değer bir temettü ödemiyor.
Hissedarlara Nakit Ödeme
Nakit Akışı Kapsamı: WCH herhangi bir ödeme bildirmediğinden temettülerin sürdürülebilirliği hesaplanamıyor.
Güçlü temettü ödeyen şirketleri keşfedin
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/09/11 13:36 |
| Gün Sonu Hisse Fiyatı | 2026/09/11 00:00 |
| Kazançlar | 2026/06/30 |
| Yıllık Kazançlar | 2025/12/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına Github sayfamızdan ulaşabilirsiniz; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube’da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Wacker Chemie AG 31 Bu analistlerden 11, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Volker Bosse | Baader Helvea Equity Research |
| Konstantin Wiechert | Baader Helvea Equity Research |
| Laura Lopez Pineda | Baader Helvea Equity Research |